Charles Schwab Investment Management Inc Charles River Laboratories International, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 545,749 shares of CRL stock, worth $107 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
545,749
Previous 577,322 5.47%
Holding current value
$107 Million
Previous $86.9 Million 4.71%
% of portfolio
0.01%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$99.75 - $151.89 $3.15 Million - $4.8 Million
-31,573 Reduced 5.47%
545,749 $82.8 Million
Q1 2025

Sep 15, 2025
BUY
$150.52 - $190.14 $4.75 Million - $6 Million
31,573 Added 5.79%
577,322 $86.9 Million
Q1 2025

May 09, 2025
BUY
$150.52 - $190.14 $3.66 Million - $4.63 Million
24,347 Added 4.4%
577,322 $86.9 Million
Q4 2024

Feb 06, 2025
BUY
$178.58 - $220.69 $6.74 Million - $8.33 Million
37,753 Added 7.33%
552,975 $102 Million
Q3 2024

Nov 12, 2024
BUY
$187.96 - $245.29 $6.07 Million - $7.93 Million
32,311 Added 6.69%
515,222 $101 Million
Q2 2024

Aug 12, 2024
BUY
$206.39 - $268.73 $7.04 Million - $9.16 Million
34,102 Added 7.6%
482,911 $99.8 Million
Q1 2024

May 08, 2024
SELL
$203.52 - $273.43 $13.1 Million - $17.6 Million
-64,418 Reduced 12.55%
448,809 $122 Million
Q4 2023

Feb 06, 2024
BUY
$164.52 - $238.84 $3.46 Million - $5.02 Million
21,028 Added 4.27%
513,227 $121 Million
Q3 2023

Nov 08, 2023
BUY
$194.44 - $217.61 $2.15 Million - $2.41 Million
11,053 Added 2.3%
492,199 $96.5 Million
Q2 2023

Aug 09, 2023
BUY
$183.71 - $210.25 $1.32 Million - $1.51 Million
7,177 Added 1.51%
481,146 $101 Million
Q1 2023

May 11, 2023
BUY
$191.89 - $259.92 $1.99 Million - $2.69 Million
10,364 Added 2.24%
473,969 $95.7 Million
Q4 2022

Feb 13, 2023
BUY
$197.11 - $250.07 $4.42 Million - $5.61 Million
22,438 Added 5.09%
463,605 $101 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $24.5 Million - $33.7 Million
134,509 Added 43.86%
441,167 $86.8 Million
Q2 2022

Aug 15, 2022
BUY
$204.13 - $302.4 $3.82 Million - $5.66 Million
18,733 Added 6.51%
306,658 $65.6 Million
Q1 2022

May 13, 2022
BUY
$255.51 - $362.11 $3.54 Million - $5.02 Million
13,865 Added 5.06%
287,925 $81.8 Million
Q4 2021

Feb 11, 2022
SELL
$351.38 - $448.68 $111,036 - $141,782
-316 Reduced 0.12%
274,060 $103 Million
Q3 2021

Nov 16, 2021
SELL
$372.64 - $458.3 $38.5 Million - $47.3 Million
-103,186 Reduced 27.33%
274,376 $113 Million
Q2 2021

Aug 16, 2021
BUY
$294.17 - $371.65 $27.9 Million - $35.2 Million
94,810 Added 33.53%
377,562 $140 Million
Q1 2021

May 17, 2021
SELL
$249.67 - $299.48 $3.74 Million - $4.49 Million
-14,976 Reduced 5.03%
282,752 $82 Million
Q4 2020

Feb 16, 2021
SELL
$222.0 - $252.62 $702,408 - $799,289
-3,164 Reduced 1.05%
297,728 $74.4 Million
Q3 2020

Nov 13, 2020
SELL
$175.56 - $226.45 $20 Million - $25.8 Million
-113,749 Reduced 27.43%
300,892 $68.1 Million
Q2 2020

Aug 14, 2020
SELL
$118.84 - $189.72 $603,350 - $963,208
-5,077 Reduced 1.21%
414,641 $72.3 Million
Q1 2020

May 15, 2020
BUY
$98.9 - $178.34 $2.18 Million - $3.93 Million
22,020 Added 5.54%
419,718 $53 Million
Q4 2019

Feb 07, 2020
BUY
$126.05 - $152.76 $999,954 - $1.21 Million
7,933 Added 2.04%
397,698 $60.8 Million
Q3 2019

Nov 08, 2019
BUY
$125.07 - $143.67 $3.86 Million - $4.44 Million
30,884 Added 8.61%
389,765 $51.6 Million
Q2 2019

Aug 09, 2019
SELL
$123.4 - $148.55 $12.6 Million - $15.1 Million
-101,910 Reduced 22.12%
358,881 $50.9 Million
Q1 2019

May 14, 2019
BUY
$104.82 - $146.73 $7.04 Million - $9.85 Million
67,125 Added 17.05%
460,791 $66.9 Million
Q4 2018

Feb 14, 2019
SELL
$105.09 - $137.23 $443,164 - $578,698
-4,217 Reduced 1.06%
393,666 $44.6 Million
Q3 2018

Nov 13, 2018
BUY
$112.11 - $134.54 $1.72 Million - $2.06 Million
15,301 Added 4.0%
397,883 $53.5 Million
Q2 2018

Aug 08, 2018
BUY
$102.37 - $117.25 $8.24 Million - $9.44 Million
80,519 Added 26.66%
382,582 $42.9 Million
Q1 2018

May 07, 2018
BUY
$98.19 - $115.2 $1.24 Million - $1.46 Million
12,670 Added 4.38%
302,063 $32.2 Million
Q4 2017

Jan 17, 2018
BUY
$100.43 - $118.09 $665,650 - $782,700
6,628 Added 2.34%
289,393 $31.7 Million
Q3 2017

Nov 13, 2017
BUY
$96.72 - $109.26 $27.3 Million - $30.9 Million
282,765
282,765 $30.5 Million

Others Institutions Holding CRL

# of Institutions
630
Shares Held
52.5M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email